These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6651402)

  • 1. Effect of Ca2+-entry blockade and serotonergic antagonism on contractions of hypoxic isolated canine coronary arteries.
    Van Nueten JM; Van Beek J; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):172-6. PubMed ID: 6651402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate.
    Van Neuten JM; Van Beek J; Vanhoutte PM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):179-87. PubMed ID: 7359366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of ketanserin on ergonovine-induced contractions of isolated canine coronary arteries.
    Van Beek J; Janssen PA; Van Nueten JM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):167-71. PubMed ID: 6651401
    [No Abstract]   [Full Text] [Related]  

  • 6. Ketanserin and vascular contractions in response to cooling.
    Van Nueten JM; De Ridder W; Vanhoutte PM
    Eur J Pharmacol; 1984 Apr; 99(4):329-32. PubMed ID: 6734731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the Ca2+ antagonist lidoflazine on normoxic and anoxic contractions of canine coronary arterial smooth muscle.
    van Nueten JM; Vanhoutte PM
    Eur J Pharmacol; 1980 Jun; 64(2-3):173-6. PubMed ID: 7398761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
    Montiel C; Herrero CJ; García-Palomero E; Renart J; García AG; Lomax RB
    Eur J Pharmacol; 1997 Aug; 332(2):183-93. PubMed ID: 9286620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunarizine inhibits endothelium-dependent hypoxic facilitation in canine coronary arteries through an action on vascular smooth muscle.
    Iqbal A; Vanhoutte PM
    Br J Pharmacol; 1988 Nov; 95(3):789-94. PubMed ID: 3207994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-induced vasoconstriction in dog kidney.
    Takahashi T; Hisa H; Satoh S
    J Cardiovasc Pharmacol; 1992; 20(5):779-84. PubMed ID: 1280741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anoxic contractions in isolated canine cerebral arteries: contribution of endothelium-derived factors, metabolites of arachidonic acid, and calcium entry.
    Katusic ZS; Vanhoutte PM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S97-101. PubMed ID: 2433536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors.
    Brazenor RM; Angus JA
    J Pharmacol Exp Ther; 1981 Aug; 218(2):530-6. PubMed ID: 6114172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prominent role of intracellular Ca2+ release in hypoxic vasoconstriction of canine pulmonary artery.
    Jabr RI; Toland H; Gelband CH; Wang XX; Hume JR
    Br J Pharmacol; 1997 Sep; 122(1):21-30. PubMed ID: 9298524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined 5-HT2 receptor and calcium channel inhibitor LU49938 restores endothelium dependent responses in the regenerated endothelium of the porcine coronary artery.
    Park SJ; Lee JJ; Kirchengast M; Boulanger CM; Vanhoutte PM
    Cardiovasc Res; 1995 Jan; 29(1):95-101. PubMed ID: 7895245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular reactivity and calcium-entry blockers.
    Van Nueten JM; De Clerck F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():575-83. PubMed ID: 6233852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term, high-altitude hypoxia on tension and intracellular calcium responses in coronary arteries of fetal and adult sheep.
    Kono S; Stiffel VM; Gilbert RD
    J Soc Gynecol Investig; 2006 Jan; 13(1):11-8. PubMed ID: 16303320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of specific receptors and calcium mechanisms in serotonergic contractile response of isolated cerebral and peripheral arteries from rats.
    Chang JY; Owman C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):629-36. PubMed ID: 3612555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-hydroxytryptamine on canine isolated coronary arteries.
    Porquet MF; Pourrias B; Santamaria R
    Br J Pharmacol; 1982 Feb; 75(2):305-10. PubMed ID: 7186819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.